Global Albumin Market Size, Share & Trends Analysis Report, By Type (Human Serum, Bovine Serum, Recombinant), By Application (Drug Formulation, Therapeutics, and Others), By End user (Hospitals & Clinics, Pharmaceutical Companies, and Research Institutions), and By Region, And Segment Forecasts, Till : 2030

Report ID : AMR1005016 | Industries : Others | Published On :January 2024 | Page Count : 212

Global Albumin Market Size, Share & Trends Analysis Report, By Type (Human Serum, Bovine Serum, Recombinant), By Application (Drug Formulation, Therapeutics, and Others), By End user (Hospitals & Clinics, Pharmaceutical Companies, and Research Institutions), and By Region, And Segment Forecasts, Till – 2030

Market Overview

According to Analytical Market Research, the global Albumin market estimated at USD 5.62 billion in 2022 and will expand at a compound annual growth rate (CAGR) of 5.44% from 2023 to 2030. Key players in the Albumin market employ various strategies to maintain and enhance their market presence. These strategies help key players capture a significant market share and remain competitive in the dynamic Albumin market. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated includes proficient analysis, predictive analysis, prescriptive analysis, cumulative analysis, and value chain analysis.

Albumin MARKET DYNAMICS: KEY DRIVERS & RESTRAINTS

Therapeutic Applications in Healthcare Drives the Market
Albumin is widely used in the healthcare industry for therapeutic applications. It is utilized as a blood plasma expander to treat conditions such as hypovolemia and hypoproteinemia. Additionally, albumin is employed in critical care settings, surgery, and trauma patients.
Potential for Transmissible Diseases may restrain market growth
The use of human plasma-derived albumin carries a potential risk of transmitting infectious diseases. Strict screening and testing protocols are in place but concerns about the safety of blood-derived products may impact market acceptance.

How are Segments Performing in the Global Albumin Market?

Albumin Type Segment Breakdown
According to Analytical Market Research, the Albumin market by type is segmented into Human Serum, Bovine Serum, and Recombinant.
Albumin Application Segment Breakdown
According to Analytical Market Research, based on application, the market is categorized into Drug Formulation, Therapeutics, and Others.
Albumin End-user Segment Breakdown
According to Analytical Market Research, based on curing mechanism, the market is categorized into Hospitals & Clinics, Pharmaceutical Companies, and Research Institutions.
Albumin Geographic Exploration
According to Analytical Market Research, the North American region is predicted to dominate the market, owing to the presence of a well-developed healthcare infrastructure and advanced research and development activities in the region. Other regions competing in the market are Asia Pacific, Europe, Middle East and Africa and Latin America respectively.

Noticeable Players Functioning in The Global Albumin Market Include:

• Octapharma AG
• Albumedix Ltd.
• Biotest AG
• Grifols SA
• HiMedia Laboratories
• Medxbio Pte Ltd.
• CSL Limited
• Merck KGaA
• Takeda Pharmaceutical Company Limited
• Ventria Bioscience Inc

KEY BREAKDOWN: Albumin Market

By Type:
• Human Serum
• Bovine Serum
• Recombinant
By Application:
• Drug Formulation
• Therapeutics
• Others
By End-user:
• Hospitals & Clinics
• Pharmaceutical Companies
• Research Institutions
Geographical Exploration:
• North America
o The USA
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o South East Asia
o Rest of Asia Pacific
• Latin America
o Brazil
o Argentina
o Rest of Latin America
• Middle East and Africa
o GCC Countries
o South Africa
o Rest of MEA

1. Research Methodology
1.1. Global Albumin Market Snapshot, 2023 and 2030
1.2. Data Mining
1.3. Validation
1.4. Primary Interviews
1.5. List of Data End users
1.6. Future Market Projections
1.7. Industry Developments and Key Market Events
2. Executive Summary
3. Market Overview
3.1. Market Scope and Definition
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunity
3.2.4. Challenges
3.2.5. Cumulative Impact due to Recent Energy Crisis
3.2.6. Cumulative Impact due to Nearing Economic Downturn
3.2.7. Post Covid-19 World Supply & Demand Conditions
3.2.8. Cumulative Impact of Russia-Ukraine Conflict
3.2.9. Key Trends
3.3. Albumin Market: Value Chain
3.3.1. List of Raw Material Supplier
3.3.2. List of Manufacturers
3.3.3. List of Applications
3.4. Porter Five Force’s Analysis
3.5. Regulatory and Technology Landscape
4. Global Albumin Market Outlook: Forecast (2023 – 2030)
4.1. Key Highlights
4.1.1. Market Size and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Current Market Size Forecast, 2023–2030
4.3. Global Albumin Market Outlook: Type
4.3.1. Introduction / Key Findings
4.3.2. Market Size (US$ Mn) and Forecast Type, 2023 – 2030
4.3.2.1. Human Serum
4.3.2.2. Bovine Serum
4.3.2.3. Recombinant
4.4. Market Attractiveness Analysis: Component
4.5. Global Albumin Market Outlook: Application
4.5.1. Introduction / Key Findings
4.5.2. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
4.5.2.1. Drug Formulation
4.5.2.2. Therapeutics
4.5.2.3. Others
4.6. Global Albumin Market Outlook: End user
4.6.1. Introduction / Key Findings
4.6.2. Market Size (US$ Mn) and Forecast Type, 2023 – 2030
4.6.2.1. Hospitals & Clinics
4.6.2.2. Pharmaceutical Companies
4.6.2.3. Research Institutions
5. Global Albumin Market Outlook: Region
5.1. Key Highlights
5.2. Market Size (US$ Mn) and Forecast By Region, 2023 – 2030
5.2.1. North America
5.2.2. Europe
5.2.3. Asia Pacific
5.2.4. Latin America
5.2.5. Middle East & Africa (MEA)
6. North America Albumin Market Outlook: Forecast (2023 – 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Application
6.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
6.4.1. U.S.
6.4.2. Canada
6.4.3. Mexico
6.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
6.5.1. Human Serum
6.5.2. Bovine Serum
6.5.3. Recombinant
6.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
6.6.1. Drug Formulation
6.6.2. Therapeutics
6.6.3. Others
6.7. Market Size (US$ Mn) and Forecast By End user, 2023 – 2030
6.7.1. Hospitals & Clinics
6.7.2. Pharmaceutical Companies
6.7.3. Research Institutions
7. Europe Albumin Market Outlook: Forecast (2023 – 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
7.3.1. By Country
7.3.2. By Type
7.3.3. By Application
7.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
7.4.1. Germany
7.4.2. France
7.4.3. U.K.
7.4.4. Russia
7.4.5. Italy
7.4.6. Spain
7.4.7. Rest of Europe
7.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
7.5.1. Human Serum
7.5.2. Bovine Serum
7.5.3. Recombinant
7.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
7.6.1. Drug Formulation
7.6.2. Therapeutics
7.6.3. Others
7.7. Market Size (US$ Mn) and Forecast By End user, 2023 – 2030
7.7.1. Hospitals & Clinics
7.7.2. Pharmaceutical Companies
7.7.3. Research Institutions
8. Asia Pacific Albumin Market Outlook: Forecast (2023 – 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
8.3.1. By Country
8.3.2. By Type
8.3.3. By Application
8.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. New Zealand
8.4.7. Singapore
8.4.8. Malaysia
8.4.9. Rest of Asia
8.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
8.5.1. Human Serum
8.5.2. Bovine Serum
8.5.3. Recombinant
8.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
8.6.1. Drug Formulation
8.6.2. Therapeutics
8.6.3. Others
8.7. Market Size (US$ Mn) and Forecast By End user, 2023 – 2030
8.7.1. Hospitals & Clinics
8.7.2. Pharmaceutical Companies
8.7.3. Research Institutions
9. Latin America Albumin Market Outlook: Forecast (2023 – 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Market Size (US$ Mn) and Analysis By Market, 2023 – 2030
9.3.1. By Country
9.3.2. By Type
9.3.3. By Application
9.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Colombia
9.4.4. Peru
9.4.5. Chile
9.4.6. Venezuela
9.4.7. Rest of Latin America
9.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
9.5.1. Human Serum
9.5.2. Bovine Serum
9.5.3. Recombinant
9.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
9.6.1. Drug Formulation
9.6.2. Therapeutics
9.6.3. Others
9.7. Market Size (US$ Mn) and Forecast By End user, 2023 – 2030
9.7.1. Hospitals & Clinics
9.7.2. Pharmaceutical Companies
9.7.3. Research Institutions
10. Middle East & Africa Albumin Market Outlook: Forecast (2023 – 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2023 – 2030
10.3.1. By Country
10.3.2. By Type
10.3.3. By Application
10.4. Market Size (US$ Mn) and Forecast By Country, 2023 – 2030
10.4.1. Saudi Arabia
10.4.2. UAE
10.4.3. Egypt
10.4.4. Kuwait
10.4.5. South Africa
10.4.6. Rest of Middle East & Africa
10.5. Market Size (US$ Mn) and Forecast By Type, 2023 – 2030
10.5.1. Human Serum
10.5.2. Bovine Serum
10.5.3. Recombinant
10.6. Market Size (US$ Mn) and Forecast By Application, 2023 – 2030
10.6.1. Drug Formulation
10.6.2. Therapeutics
10.6.3. Others
10.7. Market Size (US$ Mn) and Forecast By End user, 2023 – 2030
10.7.1. Hospitals & Clinics
10.7.2. Pharmaceutical Companies
10.7.3. Research Institutions
11. Competition Analysis
11.1. Market Share Analysis Of Top Vendors
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Key Development Strategies
11.3. Company Profiles
11.3.1. Octapharma AG
11.3.1.1. Overview
11.3.1.2. Offerings
11.3.1.3. Business Segment & Geographic Overview
11.3.1.4. Key Financials
11.3.1.5. Key Market Developments
11.3.1.6. Key Market Strategy
11.3.2. Albumedix Ltd.
11.3.3. Biotest AG
11.3.4. Grifols SA
11.3.5. HiMedia Laboratories
11.3.6. Medxbio Pte Ltd.
11.3.7. CSL Limited
11.3.8. Merck KGaA
11.3.9. Takeda Pharmaceutical Company Limited
11.3.10. Ventria Bioscience Inc